AI for Drug Discovery Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

AI for Drug Discovery Market to 2027 - Global Analysis and Forecasts By Drug Type (Small Molecule, Large Molecules); Technology (Deep Learning, Machine Learning); Application (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Others); End User (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, Others) and Geography

Report Code: TIPRE00004177 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
MARKET INTRODUCTION
Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity.

MARKET DYNAMICS
The AI for drug discovery market is expected to grow during the forecast period due to the increasing number of cross-industry partnerships & collaborations, a significant growth in venture capital investments, rise in importance of drug discovery and increase in funding of the R&D activities for the use of AI technology in the field of drug discovery. However, limited awareness, unwillingness among medical practitioners to adopt AI-based technologies, unclear regulatory guidelines for medical software and lack of interoperability among AI solutions offered by different vendors are likely to hamper the growth of the market in the forecast period.

MARKET SCOPE
The "Global AI for Drug Discovery Market Analysis to 2027" is a specialized and in-depth study of the healthcare IT industry with a special focus on the global market trend analysis. The report aims to provide an overview of enteral feeding formulas market with detailed market segmentation by drug type, technology, application, end user and geography. The global AI for drug discovery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global AI for drug discovery market is segmented on the basis of drug type, technology, application, and end user. On the basis of drug type, the market is classified as small molecule and large molecules. Based on technology, the market is classified as deep learning and machine learning. Based on application, the market is classified as metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases, and others. On the basis of end user, the market is classified as pharmaceutical & biotechnological companies, academic & research institutes, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global AI for drug discovery market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The AI for drug discovery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting AI for drug discovery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the AI for drug discovery market in these regions.

MARKET PLAYERS
The reports cover key developments in the AI for drug discovery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from AI for drug discovery market are anticipated to lucrative growth opportunities in the future with the rising demand for AI for drug discovery in the global market. Below mentioned is the list of few companies engaged in the AI for drug discovery market.

The report also includes the profiles of key AI for drug discovery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Atomwise, Inc.
  • Insilico Medicine
  • BIOAGE
  • Numerate
  • NuMedii, Inc.
  • Envisagenics
  • Cloud Pharmaceuticals, Inc.
  • BenevolentAI
  • twoXAR, Incorporated
  • Exscientia
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 AI for Drug Discovery Market - By Drug Type
1.3.2 AI for Drug Discovery Market - By Technology
1.3.3 AI for Drug Discovery Market - By Application
1.3.4 AI for Drug Discovery Market - By End User
1.3.5 AI for Drug Discovery Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. AI FOR DRUG DISCOVERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AI FOR DRUG DISCOVERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. AI FOR DRUG DISCOVERY MARKET - GLOBAL MARKET ANALYSIS
6.1. AI FOR DRUG DISCOVERY - GLOBAL MARKET OVERVIEW
6.2. AI FOR DRUG DISCOVERY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. AI FOR DRUG DISCOVERY MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. SMALL MOLECULE
7.3.1. Overview
7.3.2. Small Molecule Market Forecast and Analysis
7.4. LARGE MOLECULES
7.4.1. Overview
7.4.2. Large Molecules Market Forecast and Analysis
8. AI FOR DRUG DISCOVERY MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. DEEP LEARNING
8.3.1. Overview
8.3.2. Deep Learning Market Forecast and Analysis
8.4. MACHINE LEARNING
8.4.1. Overview
8.4.2. Machine Learning Market Forecast and Analysis
9. AI FOR DRUG DISCOVERY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. METABOLIC DISEASE
9.3.1. Overview
9.3.2. Metabolic Disease Market Forecast and Analysis
9.4. CARDIOVASCULAR DISEASE
9.4.1. Overview
9.4.2. Cardiovascular Disease Market Forecast and Analysis
9.5. ONCOLOGY
9.5.1. Overview
9.5.2. Oncology Market Forecast and Analysis
9.6. NEURODEGENERATIVE DISEASES
9.6.1. Overview
9.6.2. Neurodegenerative Diseases Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. AI FOR DRUG DISCOVERY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical & Biotechnological Companies Market Forecast and Analysis
10.4. ACADEMIC & RESEARCH INSTITUTES
10.4.1. Overview
10.4.2. Academic & Research Institutes Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. AI FOR DRUG DISCOVERY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America AI for Drug Discovery Market Overview
11.1.2 North America AI for Drug Discovery Market Forecasts and Analysis
11.1.3 North America AI for Drug Discovery Market Forecasts and Analysis - By Drug Type
11.1.4 North America AI for Drug Discovery Market Forecasts and Analysis - By Technology
11.1.5 North America AI for Drug Discovery Market Forecasts and Analysis - By Application
11.1.6 North America AI for Drug Discovery Market Forecasts and Analysis - By End User
11.1.7 North America AI for Drug Discovery Market Forecasts and Analysis - By Countries
11.1.7.1 United States AI for Drug Discovery Market
11.1.7.1.1 United States AI for Drug Discovery Market by Drug Type
11.1.7.1.2 United States AI for Drug Discovery Market by Technology
11.1.7.1.3 United States AI for Drug Discovery Market by Application
11.1.7.1.4 United States AI for Drug Discovery Market by End User
11.1.7.2 Canada AI for Drug Discovery Market
11.1.7.2.1 Canada AI for Drug Discovery Market by Drug Type
11.1.7.2.2 Canada AI for Drug Discovery Market by Technology
11.1.7.2.3 Canada AI for Drug Discovery Market by Application
11.1.7.2.4 Canada AI for Drug Discovery Market by End User
11.1.7.3 Mexico AI for Drug Discovery Market
11.1.7.3.1 Mexico AI for Drug Discovery Market by Drug Type
11.1.7.3.2 Mexico AI for Drug Discovery Market by Technology
11.1.7.3.3 Mexico AI for Drug Discovery Market by Application
11.1.7.3.4 Mexico AI for Drug Discovery Market by End User
11.2. EUROPE
11.2.1 Europe AI for Drug Discovery Market Overview
11.2.2 Europe AI for Drug Discovery Market Forecasts and Analysis
11.2.3 Europe AI for Drug Discovery Market Forecasts and Analysis - By Drug Type
11.2.4 Europe AI for Drug Discovery Market Forecasts and Analysis - By Technology
11.2.5 Europe AI for Drug Discovery Market Forecasts and Analysis - By Application
11.2.6 Europe AI for Drug Discovery Market Forecasts and Analysis - By End User
11.2.7 Europe AI for Drug Discovery Market Forecasts and Analysis - By Countries
11.2.7.1 Germany AI for Drug Discovery Market
11.2.7.1.1 Germany AI for Drug Discovery Market by Drug Type
11.2.7.1.2 Germany AI for Drug Discovery Market by Technology
11.2.7.1.3 Germany AI for Drug Discovery Market by Application
11.2.7.1.4 Germany AI for Drug Discovery Market by End User
11.2.7.2 France AI for Drug Discovery Market
11.2.7.2.1 France AI for Drug Discovery Market by Drug Type
11.2.7.2.2 France AI for Drug Discovery Market by Technology
11.2.7.2.3 France AI for Drug Discovery Market by Application
11.2.7.2.4 France AI for Drug Discovery Market by End User
11.2.7.3 Italy AI for Drug Discovery Market
11.2.7.3.1 Italy AI for Drug Discovery Market by Drug Type
11.2.7.3.2 Italy AI for Drug Discovery Market by Technology
11.2.7.3.3 Italy AI for Drug Discovery Market by Application
11.2.7.3.4 Italy AI for Drug Discovery Market by End User
11.2.7.4 Spain AI for Drug Discovery Market
11.2.7.4.1 Spain AI for Drug Discovery Market by Drug Type
11.2.7.4.2 Spain AI for Drug Discovery Market by Technology
11.2.7.4.3 Spain AI for Drug Discovery Market by Application
11.2.7.4.4 Spain AI for Drug Discovery Market by End User
11.2.7.5 United Kingdom AI for Drug Discovery Market
11.2.7.5.1 United Kingdom AI for Drug Discovery Market by Drug Type
11.2.7.5.2 United Kingdom AI for Drug Discovery Market by Technology
11.2.7.5.3 United Kingdom AI for Drug Discovery Market by Application
11.2.7.5.4 United Kingdom AI for Drug Discovery Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific AI for Drug Discovery Market Overview
11.3.2 Asia-Pacific AI for Drug Discovery Market Forecasts and Analysis
11.3.3 Asia-Pacific AI for Drug Discovery Market Forecasts and Analysis - By Drug Type
11.3.4 Asia-Pacific AI for Drug Discovery Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific AI for Drug Discovery Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific AI for Drug Discovery Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific AI for Drug Discovery Market Forecasts and Analysis - By Countries
11.3.7.1 Australia AI for Drug Discovery Market
11.3.7.1.1 Australia AI for Drug Discovery Market by Drug Type
11.3.7.1.2 Australia AI for Drug Discovery Market by Technology
11.3.7.1.3 Australia AI for Drug Discovery Market by Application
11.3.7.1.4 Australia AI for Drug Discovery Market by End User
11.3.7.2 China AI for Drug Discovery Market
11.3.7.2.1 China AI for Drug Discovery Market by Drug Type
11.3.7.2.2 China AI for Drug Discovery Market by Technology
11.3.7.2.3 China AI for Drug Discovery Market by Application
11.3.7.2.4 China AI for Drug Discovery Market by End User
11.3.7.3 India AI for Drug Discovery Market
11.3.7.3.1 India AI for Drug Discovery Market by Drug Type
11.3.7.3.2 India AI for Drug Discovery Market by Technology
11.3.7.3.3 India AI for Drug Discovery Market by Application
11.3.7.3.4 India AI for Drug Discovery Market by End User
11.3.7.4 Japan AI for Drug Discovery Market
11.3.7.4.1 Japan AI for Drug Discovery Market by Drug Type
11.3.7.4.2 Japan AI for Drug Discovery Market by Technology
11.3.7.4.3 Japan AI for Drug Discovery Market by Application
11.3.7.4.4 Japan AI for Drug Discovery Market by End User
11.3.7.5 South Korea AI for Drug Discovery Market
11.3.7.5.1 South Korea AI for Drug Discovery Market by Drug Type
11.3.7.5.2 South Korea AI for Drug Discovery Market by Technology
11.3.7.5.3 South Korea AI for Drug Discovery Market by Application
11.3.7.5.4 South Korea AI for Drug Discovery Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa AI for Drug Discovery Market Overview
11.4.2 Middle East and Africa AI for Drug Discovery Market Forecasts and Analysis
11.4.3 Middle East and Africa AI for Drug Discovery Market Forecasts and Analysis - By Drug Type
11.4.4 Middle East and Africa AI for Drug Discovery Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa AI for Drug Discovery Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa AI for Drug Discovery Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa AI for Drug Discovery Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa AI for Drug Discovery Market
11.4.7.1.1 South Africa AI for Drug Discovery Market by Drug Type
11.4.7.1.2 South Africa AI for Drug Discovery Market by Technology
11.4.7.1.3 South Africa AI for Drug Discovery Market by Application
11.4.7.1.4 South Africa AI for Drug Discovery Market by End User
11.4.7.2 Saudi Arabia AI for Drug Discovery Market
11.4.7.2.1 Saudi Arabia AI for Drug Discovery Market by Drug Type
11.4.7.2.2 Saudi Arabia AI for Drug Discovery Market by Technology
11.4.7.2.3 Saudi Arabia AI for Drug Discovery Market by Application
11.4.7.2.4 Saudi Arabia AI for Drug Discovery Market by End User
11.4.7.3 U.A.E AI for Drug Discovery Market
11.4.7.3.1 U.A.E AI for Drug Discovery Market by Drug Type
11.4.7.3.2 U.A.E AI for Drug Discovery Market by Technology
11.4.7.3.3 U.A.E AI for Drug Discovery Market by Application
11.4.7.3.4 U.A.E AI for Drug Discovery Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America AI for Drug Discovery Market Overview
11.5.2 South and Central America AI for Drug Discovery Market Forecasts and Analysis
11.5.3 South and Central America AI for Drug Discovery Market Forecasts and Analysis - By Drug Type
11.5.4 South and Central America AI for Drug Discovery Market Forecasts and Analysis - By Technology
11.5.5 South and Central America AI for Drug Discovery Market Forecasts and Analysis - By Application
11.5.6 South and Central America AI for Drug Discovery Market Forecasts and Analysis - By End User
11.5.7 South and Central America AI for Drug Discovery Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil AI for Drug Discovery Market
11.5.7.1.1 Brazil AI for Drug Discovery Market by Drug Type
11.5.7.1.2 Brazil AI for Drug Discovery Market by Technology
11.5.7.1.3 Brazil AI for Drug Discovery Market by Application
11.5.7.1.4 Brazil AI for Drug Discovery Market by End User
11.5.7.2 Argentina AI for Drug Discovery Market
11.5.7.2.1 Argentina AI for Drug Discovery Market by Drug Type
11.5.7.2.2 Argentina AI for Drug Discovery Market by Technology
11.5.7.2.3 Argentina AI for Drug Discovery Market by Application
11.5.7.2.4 Argentina AI for Drug Discovery Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. AI FOR DRUG DISCOVERY MARKET, KEY COMPANY PROFILES
13.1. ATOMWISE, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. INSILICO MEDICINE
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BIOAGE
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NUMERATE
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NUMEDII, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ENVISAGENICS
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CLOUD PHARMACEUTICALS, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BENEVOLENTAI
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. TWOXAR, INCORPORATED
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. EXSCIENTIA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Atomwise, Inc.
2. Insilico Medicine
3. BIOAGE
4. Numerate
5. NuMedii, Inc.
6. Envisagenics
7. Cloud Pharmaceuticals, Inc.
8. BenevolentAI
9. twoXAR, Incorporated
10. Exscientia